Quickly Spot Consensus Among the World’s Best Equity Analysts
| Name | Upside % |
Analysts bullish % |
|
|---|---|---|---|
|
251%
upside
3 price targets
|
0
%
|
|
|
|
247%
upside
3 price targets
|
0
%
|
|
|
|
238%
upside
5 price targets
|
0
%
|
|
|
29
C4 Therapeutics
CCCC
$263M
|
214%
upside
4 price targets
|
0
%
|
|
|
213%
upside
5 price targets
|
0
%
|
|
|
|
201%
upside
5 price targets
|
0
%
|
|
|
|
198%
upside
4 price targets
|
0
%
|
|
|
|
197%
upside
4 price targets
|
0
%
|
|
|
|
197%
upside
3 price targets
|
0
%
|
|
|
|
192%
upside
3 price targets
|
0
%
|
|
|
|
AARD
36
Aardvark Therapeutics
AARD
$217M
|
183%
upside
5 price targets
|
0
%
|
|
|
178%
upside
4 price targets
|
0
%
|
|
|
|
178%
upside
5 price targets
|
0
%
|
|
|
|
175%
upside
4 price targets
|
0
%
|
|
|
|
175%
upside
4 price targets
|
0
%
|
|
|
|
171%
upside
5 price targets
|
0
%
|
|
|
|
168%
upside
5 price targets
|
0
%
|
|
|
|
166%
upside
7 price targets
|
0
%
|
|
|
|
165%
upside
4 price targets
|
0
%
|
|
|
|
161%
upside
3 price targets
|
0
%
|
|
|
|
161%
upside
3 price targets
|
0
%
|
|
|
|
160%
upside
3 price targets
|
0
%
|
|
|
|
160%
upside
4 price targets
|
0
%
|
|
|
|
160%
upside
3 price targets
|
0
%
|
|
|
|
160%
upside
8 price targets
|
0
%
|
|